MIRA INFORM REPORT
|
Report Date : |
05.10.2013 |
IDENTIFICATION DETAILS
|
Name : |
MYLAN LABORATORIES LIMITED |
|
|
|
|
Formerly Known
As : |
MATRIX LABORATORIES LIMITTED |
|
|
|
|
Registered
Office : |
Plot No.564/A/22 Road No.92, Jubilee Hills, Hyderabad – 500 033,
Andhra Pradesh |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of Incorporation
: |
29.11.1984 |
|
|
|
|
Com. Reg. No.: |
01-005146 |
|
|
|
|
Capital
Investment/ Paid-up Capital: |
Rs. 312.680 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24231AP1984PLC005146 |
|
|
|
|
TAN No.: [Tax Deduction & Collection
Account No.] |
HYDM02247A |
|
|
|
|
PAN No.: [Permanent Account No.] |
AADCM3491M |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Active Pharmaceutical Ingredients (API). |
|
|
|
|
No. of
Employees: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (50) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 65334000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having a satisfactory track record.
The management has failed to file its financials with the Government
Department since 2011. As per available it seems that the financial strength
of the company appears to be strong and healthy. The performance capability
of the company is high. Trade relations are reported as fair. Business is active. Payments are
reported to be usually correct and as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very
High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
We are living in a
world where volatility and uncertainty have become the New Normal. We saw
a change of government in countries like Tunisia, Egypt, Libya and Vietnam.
Once powerful countries in Europe are now fighting for bankruptcy. We have
taken growth in the developing part of the world for granted but economic
growth in China and India has begun to slow. Companies that were synonymous
with their product categories just a few years ago are now no longer in
existence. Kodak, the inventor of the digital camera had to wind up its
operations, HMV, the British entertainment retailing company and Borders, once
the second largest bookstore have shut down due to their inability to evolve
their business models with the changing time. Readers’ Digest, Thomson Register
are no more !
There is another
megatrend happening. The World order is changing as economic power shifts from
West to East. According to McKinsey study, it took Britain more than 100 years
to double its economic output per person during its industrial revolution and
the US later took more than 50 years to do the same. More than a century later,
China and India have doubled their GDP per capital in 12 and 18 years respectively.
By 2020, emerging Asia will become the world’s largest consuming block,
overtaking North America.
The years after the
outbreak of the global financial crisis, the world economy continues to remain
fragile. The Indian economy demonstrated remarkable resilience in the initial
years of the contagion but finally lost ground last year. GDP growth slowed
down. Currency has been weakening. There is a marked deceleration in
agriculture, industry and services. Dampening sentiment led to a cut-back in
investment as well as private consumption expenditure. Inflation remained
at high levels fuelled by the pressure from the food and fuel sectors. The
large fiscal and current account deficit s continued to cause grave concern. It
is imperative that India regains its growth trajectory of 8-9 % sooner than
later. This is crucially important given the need to create gainful livelihood
opportunities for the millions living in poverty as also the large contingent
of young people joining the job market every year.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
AA- (Long Term Rating) |
|
Rating Explanation |
High degree of safety and very low credit
risk |
|
Date |
30.01.2013 |
|
Rating Agency Name |
CRISIL |
|
Rating |
A1+ (Short Term Debt) |
|
Rating Explanation |
Very strong degree of safety and lowest
credit risk |
|
Date |
30.01.2013 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION DECLINED
Management non-cooperative
Tel No.: 91-40-30496666
LOCATIONS
|
Registered Office : |
Plot No.564/A/22 Road No.92, Jubilee Hills, Hyderabad – 500 033,
Andhra Pradesh, India |
|
Tel. No.: |
91-40-30496666/ 23550543 |
|
Fax No.: |
91-40-27700343/ 30866699 |
|
E-Mail : |
nagaraj.bodige@matrixlabsindia.com nagarajgoud.bodige@matrixlabsindia.com apisales@maylan.in (APIs) fdfsales@mylan.in (Formulations) careers@mylan.in (Careers) |
|
Website : |
|
|
|
|
|
Factory 1: |
Survey No.10, Gaddapotharam Village, Kazipally
Industrial Estate, Jinnaram Mandal, Medak District - 502 319, Andhra Pradesh, India |
|
|
|
|
Factory 2: |
Plot Nos.38, 39, 40, 49, 50 and 51, Phase - IV, IDA, Jeedimetla,
Hyderabad - 500 055, Andhra
Pradesh, India |
|
|
|
|
Factory 3: |
Plot No.36, Phase IV, IDA, Jeedimetla, Quthbullapur
Mandal, R.R. District, Andhra Pradesh, India |
|
|
|
|
Factory 4: |
Plot No.16/B/1, S.V. Co-operative Industrial Estate,
Jeedimetla, Quthbullapur Mandal, R.R. District - 500 055, Andhra Pradesh, India |
|
|
|
|
Factory 5: |
Survey No.10/A, Model Industrial Estate,
Gaddapotharam, Jinnaram Mandal, Medak District - 502 319, Andhra Pradesh, India |
|
|
|
|
Factory 6: |
Plot Nos.14, 99 and 100, Chemical Zone, Pashamylaram, Patancheru
Mandal, Medak District - 502 319, Andhra Pradesh, India |
|
|
|
|
Factory 7: |
G. Chodavaram Village, Poosapatirega Mandal,
Vizianagaram District - 535 204, Andhra
Pradesh, India |
|
|
|
|
Factory 8: |
Plot No.5, Road No.12, J.N. Pharma City, Tadi Village,
Parawada Mandal, Visakhapatnam District, Andhra Pradesh - 531 021 |
|
|
|
|
Factory 9: |
Plot No.1A/2, MIDC, Taloja, District Raigad – 410 208,
Maharashtra, India |
|
|
|
|
Formulations Plant: |
Plot No.F-4 and F-12, MIDC, Malegaon, Sinnar, District
Nashik, Maharashtra, India |
|
|
|
|
R and D Centers 1: |
Plot No. 34/A, Anrich Industrial Estate Bollarum,
Medak District |
|
|
|
|
R and D Centers 2: |
Plot Nos.38, 39, 40, 49, 50 and 51, Phase IV, IDA,
Jeedimetla, Hyderabad, Andhra Pradesh, India |
|
|
|
|
R and D Centers 3: |
Survey No.10 and 42, Gaddapotharam, Kazipally
Industrial Area, Jinnaram Mandal, Medak District, Andhra Pradesh. |
|
|
|
|
R and D Centers 4: |
Clinical Research Centre, Saradhi Chambers A-4,
Rukminipuri, Beside Poulomi Hospital Dr. A.S. Rao Nagar, Hyderabad - 500 062
Andhra Pradesh. |
DIRECTORS
AS ON 24.09.2010
|
Name : |
Mr. Rajiv Malik |
|||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
B- 6B, Gangotri Alaaknanda, |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
12.03.1961 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Qualification : |
Degree in Pharmaceutical Industry |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
01.07.2008 |
|||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00120557 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Dr. B Hari Babu |
|||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Managing Director |
|||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
11, Sai Ansh Arcade, Duragavihar Nagar Coly, Trimulghery, Secunderabad
– 500 015, Andhra Pradesh, India |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
01.07.1964 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Qualification : |
Ph. D. and Master of Science |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
17.08.2012 |
|||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
01119687 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Sanjeev Sethi |
|||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Plot No.24, Quitelands, Gatchibowli, Hyderabad – 500 008, Andhra
Pradesh, India |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
22.07.1967 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Qualification : |
Post Graduate |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
24.09.2010 |
|||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
02168682 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Susanto Banerjee |
|||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
J1003, Spring Field Apartment, Sarjapur Road, Belan Dooru, Bangalore –
560 102, Karnataka, India |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
28.11.1966 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
28.09.2012 |
|||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00182743 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||||||||||||||||||||||||||||
KEY EXECUTIVES
|
Name : |
Mr. B Nagaraj Goud |
|
Designation : |
Secretary |
|
Address : |
H.No.5-14-88, Indiranagar Colony II APHB Colony, Movalai, Hyderabad –
500 040, Andhra Pradesh, India |
|
Date of Birth/Age : |
02.12.1977 |
|
Date of Appointment : |
07.10.2009 |
|
Pan No.: |
AGYPB3840P |
|
|
|
|
Name : |
Ms. Ashwini Khandlikar |
|
Designation : |
Company Secretary |
|
Address : |
3-4-512/58, Barakatpura, Hyderabad – 500 027, Andhra Pradesh, India |
|
Date of Birth/Age : |
01.02.1980 |
|
Date of Appointment : |
09.11.2010 |
|
PAN : |
AQAPK5399L |
|
Email : |
MAJOR SHAREHOLDERS
AS ON 24.09.2010
SHARE HOLDING DETAILS FILE ATTACHED
AS ON 24.09.2010
EQUITY SHARES BREAK – UP
|
Category |
|
Percentage |
|
Nationalized other Bank |
|
0.01 |
|
Mutual Funds |
|
0.03 |
|
Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others] |
|
0.40 |
|
Bodies corporate |
|
1.61 |
|
Other top fifty shareholders |
|
0.20 |
|
Others |
|
97.75 |
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Active Pharmaceutical Ingredients (API). |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
||||||||||||
|
|
|
||||||||||||
|
Bankers : |
|
||||||||||||
|
|
|
||||||||||||
|
Facilities : |
|
||||||||||||
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Deloitte Hasking and Sells Chartered Accounts |
|
Address : |
Gowra Grand, III Floor, 1-8-1-384- and 385, SP Road, Secunderabad –
500 003, Andhra Pradesh, India |
|
PAN No. : |
AACFD3771D |
|
|
|
|
Holding Company: |
MP Laboratories Limited,( |
|
|
|
|
Ultimate Holding Company: |
Mylan Inc. |
|
|
|
|
Associates/Subsidiaries : |
· Astrix Laboratories Limited ·
Matrix Laboratories ( ·
Matrix ·
Subsidiaries of Matrix · Matrix Laboratories Inc ·
Matrix Laboratories ( · Matrix Laboratories BVBA ·
Subsidiaries of Matrix Laboratories ( ·
Matrix Pharma Group ( · Matrix Laboratories Inc ·
Subsidiaries of Matrix Pharma Group ( · Jiangsu Matrix Pharmaceutical Chemical Company Limited · Mchem Research and Development Company Limited · Shanghai Fine Source Company Limited. ·
Matrix Laboratories( ·
Subsidiaries of Matrix Laboratories ( · Xiamen Beacon Pharmaceutical Manufacturing Company, Limited ·
Subsidiaries of Matrix Laboratories BVBA - ·
·
Subsidiaries of ·
·
·
Docpharma · Servipharma SA ·
·
· DAA Pharma SA · Farma 1 SARL · DCI Pharma SA · Hospithera SA ·
|
|
|
|
|
Fellow
Subsidiaries: |
· Mylan Pharmaceuticals Inc. · Mylan Pharmaceuticals ULC · 3 Mylan Seiyaku Limited · Gerard Laboratories Limited · Alphapharm Pty. Limited · Mylan India Private Limited ·
Mylan ( · Mylan Technologies Inc. · Mylan SAS · Mylan Newzealand Limited · Docpharma BVBA · Mylan GMBH ·
Mylan Pharmaceuticals S.L. ·
· Xixia Pharma Private Limited |
CAPITAL STRUCTURE
AS ON 31.03.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
200000000 |
Equity Shares |
Rs.2/- each |
Rs.400.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
156340000 |
Equity Shares |
Rs.2/- each |
Rs.312.680
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
312.680 |
312.680 |
309.227 |
|
|
2] Share Application Money |
0.000 |
0.000 |
82.729 |
|
|
3] Reserves & Surplus |
16020.810 |
11209.180 |
8384.030 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
16333.490 |
11521.860 |
8775.986 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
3883.690 |
4502.920 |
4488.466 |
|
|
2] Unsecured Loans |
4472.690 |
1616.130 |
1989.623 |
|
|
TOTAL BORROWING |
8356.380 |
6119.050 |
6478.089 |
|
|
DEFERRED TAX LIABILITIES |
1154.600 |
947.100 |
757.046 |
|
|
|
|
|
|
|
|
TOTAL |
25844.470 |
18588.010 |
16011.121 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
11534.430 |
8583.060 |
6131.951 |
|
|
Capital work-in-progress |
1187.650 |
1334.140 |
1475.072 |
|
|
|
|
|
|
|
|
INVESTMENT |
2617.950 |
1766.570 |
2318.980 |
|
|
DEFERRED TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
9827.240
|
6335.130 |
3763.870 |
|
|
Sundry Debtors |
5772.680
|
4843.890 |
4914.107 |
|
|
Cash & Bank Balances |
146.120
|
86.010 |
19.998 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
2465.910
|
1657.380 |
1052.080 |
|
Total
Current Assets |
18211.950
|
12922.410 |
9750.055 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
5288.710
|
3710.560 |
3332.041 |
|
|
Other Current Liabilities |
2261.330
|
2107.690 |
|
|
|
Provisions |
157.470
|
199.920 |
332.896 |
|
Total
Current Liabilities |
7707.510
|
6018.170 |
3664.937 |
|
|
Net Current Assets |
10504.440
|
6904.240 |
6085.118 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
25844.470 |
18588.010 |
16011.121 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
28444.150 |
18680.260 |
14886.750 |
|
|
|
Other Income |
1352.500 |
830.010 |
353.097 |
|
|
|
TOTAL (A) |
29796.650 |
19510.270 |
15239.847 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Consumption material Changes in Inventories |
14194.860 |
9162.290 |
|
|
|
|
Manufacturing service Expenses |
2156.480 |
1451.240 |
|
|
|
|
Employee related expenses |
1928.320 |
1344.250 |
|
|
|
|
Administrative selling other Expenses |
1774.670 |
1256.030 |
|
|
|
|
Research development expenditure |
2533.600 |
2329.440 |
|
|
|
|
TOTAL (B) |
22587.930 |
15543.250 |
11144.297 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
7208.720 |
3967.020 |
4095.550 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
432.660 |
509.810 |
509.807 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
6776.060 |
3457.210 |
3385.743 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
601.880 |
464.440 |
335.819 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
6174.180 |
2992.770 |
3249.924 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
1516.980 |
854.430 |
680.210 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
4657.200 |
2138.340 |
2569.714 |
|
|
|
|
|
|
|
|
|
|
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
5002.550 |
2864.210 |
294.496 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
9659.750 |
5002.550 |
2864.210 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
29.79 |
13.71 |
NA |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
15.63
|
10.97 |
16.86 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
21.71
|
16.02 |
21.83 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
20.76
|
13.92 |
20.46 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.38
|
0.26 |
0.37 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.51
|
0.53 |
0.74 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.36
|
2.15 |
2.66 |
LOCAL AGENCY FURTHER INFORMATION
|
Check List by Info Agents |
Available in Report (Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
No |
|
5) Type of Business |
Yes |
|
6) Line of Business |
Yes |
|
7) Promoter’s background |
Yes |
|
8) No. of employees |
No |
|
9) Name of person contacted |
No |
|
10) Designation of contact person |
No |
|
11) Turnover of firm for last three years |
Yes |
|
12) Profitability for last three years |
Yes |
|
13) Reasons for variation <> 20% |
- |
|
14) Estimation for coming financial year |
No |
|
15) Capital in the business |
Yes |
|
16) Details of sister concerns |
Yes |
|
17) Major suppliers |
No |
|
18) Major customers |
No |
|
19) Payments terms |
No |
|
20) Export / Import details (if applicable) |
No |
|
21) Market information |
- |
|
22) Litigations that the firm / promoter involved in |
- |
|
23) Banking Details |
Yes |
|
24) Banking facility details |
Yes |
|
25) Conduct of the banking account |
- |
|
26) Buyer visit details |
- |
|
27) Financials, if provided |
Yes |
|
28) Incorporation details, if applicable |
Yes |
|
29) Last accounts filed at ROC |
No |
|
30) Major Shareholders, if available |
Yes |
|
31) Date of Birth
of Proprietor/Partner/Director, if available |
Yes |
|
32) PAN of
Proprietor/Partner/Director, if available |
No |
|
33) Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34) External
Agency Rating, if available |
Yes |
|
Unsecured Loans |
31.03.2011 (Rs. in Millions) |
31.03.2010 (Rs. in Millions) |
|
Deferred sales tax loan unsecured |
27.190 |
29.510 |
|
Other debt unsecured |
4455.500 |
1586.620 |
|
Total |
4482.690 |
1616.130 |
INDEX OF CHARGES:
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10296577 |
12/08/2013 * |
480,000,000.00 |
DBS BANK LIMITED |
SALARPURIA WINDSOR,
NO.3, NO.10, ULSOOR ROAD, WARD 78, BANGALORE, KARNATAKA - 560042, INDIA |
B84460450 |
|
2 |
10268093 |
27/01/2011 |
480,000,000.00 |
DBS BANK LIMITED |
SALARPURIA
WINDSOR, NO.3, (OLD NO.10), ULSOOR ROAD, WARD NO. 78, BANGALORE, KARNATAKA - 560042,
INDIA |
B06623540 |
|
3 |
10198643 |
12/08/2013 * |
8,104,000,000.00 |
THE HONGKONG AND
SHANGHAI BANKING CORPORATION LIMITED |
6-3-1107 AND
1108, RAJ BHAVAN ROAD, SOMAJIGUDA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA |
B84182138 |
|
4 |
10198487 |
29/07/2010 * |
470,000,000.00 |
THE ROYAL BANK
OF SCOTLAND N.V. |
74, SAKHAR
BHAVAN, 7TH FLOOR, NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA |
A91987479 |
|
5 |
10179307 |
21/07/2009 |
300,000,000.00 |
INDUSIND BANK
LIMITED |
2401 GEN THIMMAYYA
ROAD, CONTONMENT, PUNE, MAHARASHTRA - 411001, INDIA |
A69552057 |
|
6 |
10179308 |
21/07/2009 |
700,000,000.00 |
INDUSIND BANK
LIMITED |
2401 GEN
THIMMAYYA ROAD, CONTONMENT, PUNE, MAHARASHTRA - 411001, INDIA |
A69552685 |
|
7 |
90128817 |
06/07/2007 * |
186,000,000.00 |
ANDHRA BANK |
R P. ROAD,
SECUNDERABAD, SECUNDERABAD, ANDHRA PRADESH - 500003, INDIA |
A19287150 |
|
8 |
90130616 |
08/06/2007 * |
434,000,000.00 |
HDFC BANK
LIMITED |
HDFC BANK HOUSESENAPATI
BAPAT MARG, LOWER PAREL WEST, MUMBAI, MAHARASHTRA - 400013, INDIA |
A19336171 |
|
9 |
90130414 |
12/08/2013 * |
700,000,000.00 |
THE ROYAL BANK
OF SCOTLAND NV |
MAKER MAXITY, 4
NORTH AVENUE, LEVEL 3, BKC, MUMBAI, MAHARASHTRA - 400051, INDIA |
B84032853 |
|
10 |
90262408 |
12/08/2013 * |
8,104,000,000.00 |
STATE BANK OF
INDIA |
CAG BRANCH, 2ND
FLOOR, OZONE BUILDING, 6-3-669, PUNJAGUTTA MAIN ROAD, HYDERABAD, ANDHRA
PRADESH - 500082, INDIA |
B84033638 |
|
11 |
90130385 |
12/08/2013 * |
1,000,000,000.00 |
THE BANK OF NOVA
SCOTIA |
6-3-346/1, ROAD
NO.1, BANJARA HILLS, HYDERABAD, ANDHRA PRADESH - 500034, INDIA |
B85301729 |
|
12 |
90130372 |
01/12/2003 |
262,500,000.00 |
HDFC BANK
LIMITED |
LAKDIKAPUL BRANCH,
SADEED PLAZA, HYDERABAD, ANDHRA PRADESH, INDIA |
- |
|
13 |
90262350 |
19/09/2003 |
120,000,000.00 |
IDBI BANK
LIMITED |
MAHAVIR HOUSE,
BASEERBAGH, HYDERABAD, ANDHRA PRADESH, INDIA |
- |
|
14 |
90262253 |
24/02/2003 |
5,000,000.00 |
COOPERATIVE CENTRALE
RAIFFEISEN - BOERENFEENBANK B |
SINGAPORE
BRANCH; 77; ROBINSON ROAD - 08 - 00, SIA BUILDING, SINGAPORE, ANDHRA PRADESH
- 068896, INDIA |
- |
|
15 |
90262220 |
14/11/2002 |
75,000,000.00 |
PUNJAB NATIONAL
BANK |
RP ROAD, SECUNDRABAD,
ANDHRA PRADESH, INDIA |
- |
|
16 |
90260738 |
25/11/1988 |
263,000.00 |
ANDHRA PRADESH
STATE FINANCIAL CORPAORATION |
CHIRAG ALI LANE,
ABIDS, HYDERABAD, ANDHRA PRADESH, INDIA |
- |
|
17 |
90260687 |
11/02/1988 |
3,635,000.00 |
AP STATE FINANCIAL
CORPORATION |
CHIRAG ALI LANE,
HYDERABAD, ANDHRA PRADESH, INDIA |
- |
* Date of charge modification
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.41 |
|
|
1 |
Rs.99.29 |
|
Euro |
1 |
Rs.83.67 |
INFORMATION DETAILS
|
Information
Gathered by : |
PLK |
|
|
|
|
Report Prepared
by : |
SMN |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTERS |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
50 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.